Delivery Order SPE2DB20D1004-SPE2DB25FNGFA
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,345.59, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG tablets. It is a firm fixed-price delivery order contract that runs through April 1, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The delivery order, valued at $1,569.18, is for the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,467.90 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corporation's Corporate Office Division to provide MYFEMBREE 40 MG-1 MG-0.5 MG tablets, a pharmaceutical product, with an ultimate completion date of October 9, 2024. This contract is not set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded on October 30, 2024, is a Firm Fixed Price Delivery Order valued at $1,180.74 with a completion date of October 31, 2024. The contract covers the procurement of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with no set-aside designation. AmerisourceBergen also holds a significant...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN2G5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.90 delivery order contract is for the medical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with a completion date of May 1, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG1TH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.13 delivery order contract is for the supply of the medication MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 5, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award (SPE2DB20D1100|SPE2DB24FB1R6) was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,726.53 fixed-price delivery order is for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the prescription medication MYFEMBREE, a combination of relugolix, estradiol, and norethindrone acetate tablets, over the period of performance ending on April 30, 2025. The contract has a ceiling value of $4,066.72 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract delivers MYFEMBREE 40/1/0.5 28S, a pharmaceutical product, with a ceiling value of $2,475.00 and a performance period through March 18, 2024. This award does not have a set-aside designation. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC) with DLA valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,530.93 delivery order contract is for the provision of Myfembree, a branded pharmaceutical product, on a firm fixed price basis. The contract has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...